Next Generation Sequencing
Flexible Sequencing Solutions
Champions' experts can help you integrate Whole Exome Sequencing (WES), RNA sequencing (RNAseq), or Whole Transcriptome Sequencing (WTS) into your preclinical studies or clinical trials to discover endless insights.
Tissue processing is available following post-study completion at our US-based facility
Fast turnaround times with reliable, high-quality data analysis
Data analysis and visualization are delivered through Lumin or analyzed by Champions' dedicated team of bioinformaticians
Uncover Deep Molecular Insights using Preclinical Next Generation Sequencing
Next Generation Sequencing (NGS) can be utilized as an endpoint for in vivo and ex vivo studies to provide a deeper understanding of the model to better stratify responders versus non-responders and to discover novel biomarkers to guide patient selection.
As oncology experts, our team has deep scientific competencies to not only aid in the planning of your upcoming in vivo or ex vivo study, but to recommend NGS endpoint analyses that can help you discover powerful insights with your therapeutic candidate from our highly characterized tumor bank.
NGS for Clinical Applications
Champions provides Next Generation Sequencing (NGS) as an exploratory endpoint for your clinical trials.
GCLP-compliant sample processing at our global facilities provides fast turnaround times with reliable, high-quality data analysis delivered using a secure cloud-based platform.
Champions computational biology experts also provides custom bioinformatic analysis through Lumin Acuity.